Testing SAL0140 doses for kidney disease with protein in urine
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a new drug called SAL0140 can help people with chronic kidney disease who have protein leaking into their urine. The study will look at different doses to find the safest and most effective amount.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with chronic kidney disease
- You have significant protein in your urine (measured by a specific urine test)
- Your blood potassium level is normal or slightly low (not too high)
- Your blood pressure is at least 120 mmHg systolic but controlled without severe high blood pressure
- You have normal or adequate morning cortisol levels (a hormone made by your adrenal gland)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called HS-10390 can slow kidney disease and reduce protein leaking into urine in people with moderate kidney damage. You must already be taking blood pressure medications (ACE inhibitors or ARBs) to qualify.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests HRS-7535, a new oral tablet that may help protect kidneys in people with chronic kidney disease. GLP-1 medications were originally developed for diabetes but may also benefit kidney function and overall health.
This study tests whether survodutide, an injected medication, can lower the amount of protein in your urine—a key sign of kidney damage. It's for people with chronic kidney disease who are already on standard blood pressure medications.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.